RAPTIVA (efalizumab)
[back] Drug list
[back]
Genentech [back]
Withdrawn drugs
[Generically known as efalizumab, Raptiva is an
injectable medication used in the treatment of psoriasis. To reduce the presence
of psoriasis plaques, Raptiva medication suppresses the immune system and
prevents white blood cells from making their way into the skin's tissues.
The Raptiva drug is produced by Genentech and Merck
Serono. Genentech recently agreed to withdraw
all of the Raptiva on the U.S. market, based on the viral infections diagnosed
in Raptiva patients in America and around the world.1.]
See: Drug induced
leukoencephalopathy,
meningitis,
viral infections
Raptiva Attorney
Despite its effectiveness at reducing psoriasis plaques, Raptiva is
currently known to cause a variety of serious, potentially fatal infections,
including: bacterial sepsis, invasive fungal disease, progressive multifocal
leukoencephalopathy (PML), viral
meningitis
Raptiva Deaths Raptiva
deaths have been reported by the U.S. Food and Drug Administration (FDA) and the
European Medicines Agency, the FDA's counterpart for the EU (European Union).
The Raptiva deaths were apparently due to PML (progressive multifocal
leukoencephalopathy), a devastating and rare brain infection.
External
Defective
Drugs: adrugrecall.com
-
Raptiva Attorney
-
Death Raptiva deaths have been reported by the U.S. Food and Drug
Administration (FDA) and the European Medicines Agency, the FDA's
counterpart for the EU (European Union). The Raptiva deaths were apparently
due to PML (progressive multifocal leukoencephalopathy), a devastating and
rare brain infection.
-
Efalizumab
-
Infections Raptiva, a medication
prescribed to treat Psoriasis, can cause viral
infections. This is admitted by Raptiva's manufacturer, Genentech, and
has been confirmed by the FDA. Indeed, the link between Raptiva and viral
infections is so clear that Genentech recently agreed to withdraw all of the
Raptiva on the U.S. market, based on the viral infections diagnosed in
Raptiva patients in America and around the world.
Prescribed to treat psoriasis, Raptiva (efalizumab) is an injectable
medication that is known to increase the risk of developing severe,
life-threatening infections, including: bacterial sepsis (a blood
infection), invasive fungal disease, progressive multifocal
leukoencephalopathy/ PML (a type of Raptiva brain infection in which the
white matter of the brain swells), viral meningitis (an infection that
causes inflammation of the brain and/or spinal cord).
While Raptiva brain infections (specifically Raptiva PML infections and
meningitis) are the most deadly
side effects, any of the above conditions will be fatal without emergency
medical care.
-
Injections
-
Lawsuits
-
Medication
-
Prescription
-
PML
-
Psoriasis
-
Raptiva
-
Recall
-
Side Effects
-
Viral Infections
-
Warnings